PHAT – phathom pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

PHAT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/13

07:50 am

phat

Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.

Low Report

Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.

Report

12/11

05:04 pm

phat

Phathom Pharmaceuticals (NASDAQ:PHAT) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.

Low Report

Phathom Pharmaceuticals (NASDAQ:PHAT) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.

Report

12/11

06:29 am

phat

Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Barclays PLC to a "hold" rating.

Low Report

Phathom Pharmaceuticals (NASDAQ:PHAT) was upgraded by analysts at Barclays PLC to a "hold" rating.

Report

12/8

06:06 pm

phat

Phathom Pharmaceuticals (NASDAQ:PHAT) was given a new $16.00 price target on by analysts at Barclays PLC.

Low Report

Phathom Pharmaceuticals (NASDAQ:PHAT) was given a new $16.00 price target on by analysts at Barclays PLC.

Report

11/21

04:07 pm

phat

Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth [Seeking Alpha]

Low Report

Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth [Seeking Alpha]

Report

11/13

12:02 am

phat

Could Clinical Progress With VOQUEZNA Reshape Phathom Pharmaceuticals' Long-Term Strategy (PHAT)? [Yahoo! Finance]

Low Report

Could Clinical Progress With VOQUEZNA Reshape Phathom Pharmaceuticals' Long-Term Strategy (PHAT)? [Yahoo! Finance]

Report

11/4

08:00 am

phat

Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Low Report

Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Report

11/3

07:59 am

phat

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Low Report

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Report

Date

Time

Symbol

Company Name

Action

%Chg

10/30/2025

07:00 am

phat

phathom pharmaceuticals, inc.

BEAT Report

-5.2%

phathom pharmaceuticals, inc.

Report

8/7/2025

06:59 am

phat

phathom pharmaceuticals, inc.

BEAT Report

8.1%

phathom pharmaceuticals, inc.

Report

5/1/2025

07:00 am

phat

phathom pharmaceuticals, inc.

BEAT Report

-18.0%

phathom pharmaceuticals, inc.

Report

3/6/2025

08:00 am

phat

phathom pharmaceuticals, inc.

BEAT Report

-3.9%

phathom pharmaceuticals, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

12/13

07:50 am

Upgrades

Strong-Buy

Raymond James Financial, Inc.

Low

Report

0.5%

Report

12/11

05:04 pm

Initiates

Strong-Buy

Raymond James Financial, Inc.

Low

Report

-1.3%

Report

12/11

04:10 pm

Initiates

STRONG BUY

RAYMOND JAMES

Low

Report

-0.1%

Report

12/11

04:10 pm

Initiates

STRONG BUY

RAYMOND JAMES

Low

Report

-0.1%

Report

12/11

06:29 am

Upgrades

Hold

Barclays PLC

Low

Report

1.3%

Report

12/9

11:05 am

Initiates

Equal-Weight

Barclays

Low

Report

-2.2%

Report

12/9

11:05 am

Initiates

Equal-Weight

Barclays

Low

Report

-2.2%

Report

12/8

04:27 pm

Initiates

EQUAL WEIGHT

BARCLAYS

Medium

Report

-4.6%

Report

Date

Time

Symbol

Headline

Impact

12/23

05:00 pm

phat

Form 4 Phathom Pharmaceuticals, For: Dec 19 Filed by: Parikh Asit

Medium Report

Form 4 Phathom Pharmaceuticals, For: Dec 19 Filed by: Parikh Asit

Report

12/19

05:51 pm

phat

Form 4 Phathom Pharmaceuticals, For: Dec 18 Filed by: Breedlove Robert Charles

Low Report

Form 4 Phathom Pharmaceuticals, For: Dec 18 Filed by: Breedlove Robert Charles

Report

12/19

05:47 pm

phat

Form 4 Phathom Pharmaceuticals, For: Dec 17 Filed by: Cook Anne Marie

Low Report

Form 4 Phathom Pharmaceuticals, For: Dec 17 Filed by: Cook Anne Marie

Report

12/19

05:46 pm

phat

Form 4 Phathom Pharmaceuticals, For: Dec 17 Filed by: Basta Steven L

Low Report

Form 4 Phathom Pharmaceuticals, For: Dec 17 Filed by: Basta Steven L

Report

12/2

06:45 pm

phat

Form 4 Phathom Pharmaceuticals, For: Nov 28 Filed by: Basta Steven L

Low Report

Form 4 Phathom Pharmaceuticals, For: Nov 28 Filed by: Basta Steven L

Report

11/5

04:30 pm

phat

Form 4 Phathom Pharmaceuticals, For: Nov 03 Filed by: Breedlove Robert Charles

Low Report

Form 4 Phathom Pharmaceuticals, For: Nov 03 Filed by: Breedlove Robert Charles

Report

11/4

05:25 pm

phat

Form SCHEDULE 13D/A Phathom Pharmaceuticals, Filed by: Frazier Life Sciences Public Fund, L.P.

Low Report

Form SCHEDULE 13D/A Phathom Pharmaceuticals, Filed by: Frazier Life Sciences Public Fund, L.P.

Report

11/4

07:05 am

phat

Form 8-K Phathom Pharmaceuticals, For: Nov 04

Low Report

Form 8-K Phathom Pharmaceuticals, For: Nov 04

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.